The Food and Drug Administration issued an untitled letter to Ascend Therapeutics for claims made in its EstroGel promotions. The offending promotional material was a sell sheet distributed to ...
The US Food and Drug Administration (FDA) issued an untitled letter Tuesday to Ascend Therapeutics over “misleading claims and/or representations” regarding an Estrogel pamphlet. “This sell sheet is ...
The FDA's promo police are back in action with the fourth untitled letter of the year—and it's a second one for Ascend Therapeutics’ estrogen therapy EstroGel. Ascend is in trouble (PDF) this time for ...
Pharmaco (NZ) Ltd welcomes the start of PHARMAC funding for Hormone Replacement Therapy (HRT) medication Estrogel®, which begins today, Friday 1st November 2024. The funding means thousands of Kiwi ...
March 11, 2004 — The U.S Food and Drug Administration (FDA) recently approved four new advances: a drug that is the first in its class for the treatment of chronic kidney disease, a new scanner for ...
Another treatment to help people to manage the symptoms of menopause is available from today. Estrogel will now be available for those requiring oestrogen to meet rising demand for hormone replacement ...
Publicly traded telemedicine company LifeMD announced it is partnering with women's health-focused specialty pharmaceutical company ASCEND Therapeutics to improve access to EstroGel, a hormone therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results